KMT2C and bladder transitional cell carcinoma: Mutations of KMT2C (MLL3) have been found in pancreatic cancer, gastric cancer, ovarian cancer, colorectal cancer, cholangiocarcinoma, bladder transitional cell carcinoma, etc. [39–42].